Manufacturing with pluripotent stem cells (PSConf 2021): Key issues for future research and development

Area of Science:

• Regenerative Medicine
• Biotechnology
• Cellular Manufacturing

Background:

• Human pluripotent stem cells (hPSCs) hold promise for treating degenerative diseases and injuries.
• Significant challenges exist in the manufacturing of hPSC-based therapies, including bioprocessing, characterization, and delivery.

Purpose of the Study:

• To summarize the proceedings and conclusions of the Pluripotent Stem Cell Conference 2021 (PSConf 2021).
• To promote international communication and coordination in hPSC manufacturing.
• To address key challenges and potential solutions in stem cell-based manufacturing.

Main Methods:

• The study summarizes discussions from PSConf 2021, a forum focused on hPSC manufacturing.
• Key topics included stem cell differentiation, culture scale-up, product formulation, and release.
• Information was exchanged among international experts, including those with early experience in human embryonic stem cells.

Main Results:

• PSConf 2021 facilitated an open exchange of information on hPSC manufacturing advancements.
• The conference identified critical challenges and explored potential solutions in cell-based medicine production.
• A diverse range of new hPSC-based medicines currently in development or clinical trials were presented.

Conclusions:

• PSConf 2021 successfully fostered international collaboration and information exchange on hPSC manufacturing.
• The meeting highlighted progress and ongoing challenges in developing novel cell-based therapies.
• Continued dialogue and coordinated efforts are crucial for advancing hPSC-based medicine manufacturing.